An insider at this FTSE 100 company just bought £700k worth of stock

This FTSE 100 healthcare stock just saw some notable insider buying. And Edward Sheldon sees this activity as a bullish signal.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 100 healthcare stock Smith & Nephew (LSE: SN.) hasn’t performed very well recently. Over the last 12 months, its share price has fallen about 9%.

What’s interesting, however, is that the chief financial officer (CFO) of the company, John Rogers, just spent a huge amount of money on shares. This suggests that he believes that the share price is about to rally.

Created with Highcharts 11.4.3Smith & Nephew Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

I follow insider transactions

I always pay attention to insider transactions, especially buys. Insiders can sell stock for a number of reasons (e.g., buying a house, paying school fees, etc.). But they generally only buy stock for one reason – to make money. So, stock purchases can provide valuable investment insights.

Should you invest £1,000 in Bunzl Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Bunzl Plc made the list?

See the 6 stocks

Now, academic research shows that not all insider buys are created equal from a signaling perspective. The most ‘informative’ buys tend to be large ones from top-tier insiders (CEO, CFO, chair, etc.). These insiders tend to have the most information on their businesses. So, the fact that they are buying shares is generally a bullish signal (it can suggest that they think the market is underestimating their businesses).

A large purchase

The recent trade from Smith & Nephew’s CFO John Rogers certainly looks interesting to me. On 19 December, he bought a total of 71,920 shares for around £9.72 per share. That equates to roughly £700,000 worth of stock. That’s a large buy, and it suggests the insider is confident in the outlook. It could be a sign that performance is going to be better than expected. But we don’t know for sure.

The stock looks cheap

One thing we do know is that the stock looks cheap today. Currently, analysts expect earnings per share to come in at $1.05 next year (versus a forecast of 89 cents for 2024). So, at today’s share price, we are looking at a price-to-earnings (P/E) ratio of just 11.6.

That’s pretty low for an orthopaedics company with a decent long-term track record and plenty of long-term growth potential (as the global population continues to age, the number of hip and knee surgeries should increase). If the company – which has struggled to generate momentum recently – can show that it’s firing on all cylinders, the stock could get a major valuation rerating.

Short-term risks

Now, there are no guarantees that this stock will do well in the short term, of course. Recently, the company has been negatively impacted by the economy in China and this remains a risk.

Government initiatives in China could also be a challenge. Recently, its volume-based procurement (VBP) programme, which is designed to lower the cost of medical products, has hurt the company.

Taking a long-term view, however (as we like to do here at The Motley Fool), this stock does appear to have plenty of potential. I think it’s worth considering for an investment portfolio, especially after the recent £700k CFO buy.

Should you buy Bunzl Plc shares today?

Before you decide, please take a moment to review this first.

Because my colleague Mark Rogers – The Motley Fool UK’s Director of Investing – has released this special report.

It’s called ‘5 Stocks for Trying to Build Wealth After 50’.

And it’s yours, free.

Of course, the decade ahead looks hazardous. What with inflation recently hitting 40-year highs, a ‘cost of living crisis’ and threat of a new Cold War, knowing where to invest has never been trickier.

And yet, despite the UK stock market recently hitting a new all-time high, Mark and his team think many shares still trade at a substantial discount, offering savvy investors plenty of potential opportunities to strike.

That’s why now could be an ideal time to secure this valuable investment research.

Mark’s ‘Foolish’ analysts have scoured the markets low and high.

This special report reveals 5 of his favourite long-term ‘Buys’.

Please, don’t make any big decisions before seeing them.

Claim your free copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has positions in Smith & Nephew Plc. The Motley Fool UK has recommended Smith & Nephew Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Value Shares

Investing Articles

Here’s the dividend forecast for Rolls-Royce shares as Trump rocks the markets

Rolls-Royce shares have joined in the volatility over the past week. However, with the direction being largely downwards, the dividend…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

£10,000 invested in NatWest shares at the start of 2025 is now worth…

NatWest shares surged into 2025, but things have become a little more complicated in recent weeks. Dr James Fox explores.

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Tariff fears send the Lloyds share price tumbling, but the dividend yield is climbing

Just when the Lloyds Banking Group share price had been rising steadily, along comes a global upheaval to knock it…

Read more »

Investing Articles

10 UK shares that are 50% or more off their 52-week highs

These UK shares have been hit hard. And Edward Sheldon believes there could be some opportunities for those with a…

Read more »

Man smiling and working on laptop
Investing Articles

Could IAG’s share price surge over the next year? These analysts think so!

IAG's share price has sunk, reflecting growing concerns over the impact of trade wars on airline profits. Is this a…

Read more »

Investing Articles

Are shares like Tesco a safe haven for investors?

Christopher Ruane sees a lot to like about Tesco shares. But does he see them as a safe heaven in…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

2 reasons why this stock market crash isn’t a repeat of 2020

When the stock market crashed during the Covid-19 pandemic, the recovery was rapid and spectacular. Could the same thing happen…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

£10,000 invested in Watches of Switzerland shares 1 year ago is now worth…

Watches of Switzerland shares have been decimated by Trump’s tariffs on Switzerland. Dr James Fox explores whether this is an…

Read more »